Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Isoscopoletin

Copy Product Info
😃Good
Catalog No. T3815Cas No. 776-86-3
Alias 7-Methoxyesculetin, 6-Hydroxy-7-methoxycoumarin

Isoscopoletin (7-Methoxyesculetin) is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 6, 7-dimethoxy-2h-chromen-2-one.

Isoscopoletin

Isoscopoletin

Copy Product Info
😃Good
Purity: 99.96%
Catalog No. T3815Alias 7-Methoxyesculetin, 6-Hydroxy-7-methoxycoumarinCas No. 776-86-3
Isoscopoletin (7-Methoxyesculetin) is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 6, 7-dimethoxy-2h-chromen-2-one.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$31In StockIn Stock
10 mg$56In StockIn Stock
25 mg$92In StockIn Stock
50 mg$133-In Stock
100 mg$198-In Stock
200 mg$295-In Stock
1 mL x 10 mM (in DMSO)$35In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.96%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Isoscopoletin AI Summary
Isoscopoletin exhibits a range of bioactivities across various biological targets. It acts as an inhibitor of 15-lipoxygenase (15LOX) with an IC50 value of 15100.0 nM in rabbit reticulocytes, without significant inhibition of 5LOX or human recombinant COX2. It inhibits xanthine oxidase with an IC50 of 138000.0 nM and demonstrates anti-inflammatory activity in human neutrophils by inhibiting fMLP-induced superoxide release, showing an IC50 of 77520.0 nM. The compound induces strand scission in pBR322 DNA, converting supercoiled to nicked forms, especially in the presence of Cu2+, with variable activity at different concentrations (42.0% at 1000 uM, 26.0% at 500 uM, 14.0% at 250 uM), while activity without Cu2+ is minimal (2.0% at 1000 uM). Isoscopoletin inhibits human recombinant aldose reductase 1 (IC50 of 56200.0 nM) and kidney aldose reductase 2 (IC50 of 101000.0 nM) but shows greater inhibition of sorbitol dehydrogenase (IC50 > 250000.0 nM). It selectively inhibits Polymerase Kappa with an IC50 of 23778.1 nM and exhibits 28.07% inhibition of electric eel acetylcholinesterase (AChE) at 2 mg/ml, and 3.87% inhibition of horse butyrylcholinesterase (BChE) at the same concentration. In terms of carbonic anhydrase enzymes, the compound exhibits varying Ki values: 14000.0 nM for CA1, 7370.0 nM for CA9, 5270.0 nM for CA13, and 4140.0 nM for CA12, but shows weaker inhibition of CA2 (Ki > 100000.0 nM). It inhibits mouse brain monoamine oxidase with an IC50 of 32200000.0 nM and demonstrates over 30.0% inhibition of mushroom tyrosinase at 100 uM. Furthermore, Isoscopoletin shows anti-austerity activity against nutrient-deprived human PANC1 cells with a PC50 value of 26.9 uM, and exhibits affinity for human Mcl-1 protein, displacing a specific peptide with a Ki of 15870.0 nM and an IC50 of 51480.0 nM, suggesting potential modulation of Mcl-1 function..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Isoscopoletin (7-Methoxyesculetin) is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 6, 7-dimethoxy-2h-chromen-2-one.
Synonyms7-Methoxyesculetin, 6-Hydroxy-7-methoxycoumarin
Chemical Properties
Molecular Weight192.17
FormulaC10H8O4
Cas No.776-86-3
SmilesCOc1cc2oc(=O)ccc2cc1O
Relative Density.1.37 g/cm3
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature,keep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Chloroform, Dichloromethane, Ethyl Acetate, Acetone: Soluble
DMSO: 35 mg/mL (182.13 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (10.41 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM5.2037 mL26.0186 mL52.0373 mL260.1863 mL
5 mM1.0407 mL5.2037 mL10.4075 mL52.0373 mL
10 mM0.5204 mL2.6019 mL5.2037 mL26.0186 mL
20 mM0.2602 mL1.3009 mL2.6019 mL13.0093 mL
50 mM0.1041 mL0.5204 mL1.0407 mL5.2037 mL
100 mM0.0520 mL0.2602 mL0.5204 mL2.6019 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Isoscopoletin | purchase Isoscopoletin | Isoscopoletin cost | order Isoscopoletin | Isoscopoletin chemical structure | Isoscopoletin formula | Isoscopoletin molecular weight